In a randomized study with a factorial design , 82 stable coronary artery disease patients treated with 75 mg clopidogrel MD and aspirin were assigned to receive in a double blind fashion lansoprazole ( 30 mg/day ) or placebo and to receive in an open fashion 150 mg clopidogrel MD or 10 mg prasugrel MD. .